Jeffrey Ecsedy
Corporate Officer/Principal chez IKENA ONCOLOGY, INC.
Fortune : - $ au 31/03/2024
Profil
Jeffrey Ecsedy is currently the Chief Development Officer at Ikena Oncology, Inc. He previously worked as the Senior Director & Head-Oncology Translational at Takeda Pharmaceuticals U.S.A., Inc. from 2013 to 2017.
Dr. Ecsedy holds a doctorate degree from Boston College and an undergraduate degree from the University of Connecticut.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IKENA ONCOLOGY, INC.
-.--% | 01/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jeffrey Ecsedy
| Sociétés | Poste | Début |
|---|---|---|
| IKENA ONCOLOGY, INC. | Corporate Officer/Principal | 30/11/2021 |
Anciens postes connus de Jeffrey Ecsedy
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/10/2017 |
Formation de Jeffrey Ecsedy
| Boston College | Doctorate Degree |
| University of Connecticut | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
| Ikena Oncology, Inc. |
